Cargando…
Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain
BACKGROUND: Buprenorphine is often administered by the transdermal route (transdermal buprenorphine [TB]) in cancer patients with severe neuropathic pain. However, high doses of TB of 140 µg/h are rarely used. PATIENTS AND METHODS: Three cancer patients with severe neuropathic Numeric Rating Scale (...
Autores principales: | Leppert, Wojciech, Kowalski, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675634/ https://www.ncbi.nlm.nih.gov/pubmed/26675083 http://dx.doi.org/10.2147/OTT.S91347 |
Ejemplares similares
-
A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
por: Nosek, Krzysztof, et al.
Publicado: (2017) -
Transdermal and Topical Drug Administration in the Treatment of Pain
por: Leppert, Wojciech, et al.
Publicado: (2018) -
Transdermal buprenorphine for pain management in children
por: Attinà, Giorgio, et al.
Publicado: (2021) -
Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain
por: Skaer, Tracy L
Publicado: (2014) -
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review
por: Deandrea, S, et al.
Publicado: (2009)